Potential for antioxidant therapy of cystic fibrosis
Potential for antioxidant therapy of cystic fibrosis
复制标题
DOI:
10.1097/01.mcp.0000138997.29276.a1
复制
发表时间:
2004-11-01
影响因子:
3.3
通讯作者:
Cantin, AM
中科院分区:
文献类型:
--
作者:
Cantin, AM
Purpose of review Changes in redox state clearly play a role in airway inflammation and mucus theology. Furthermore CFTR (cystic fibrosis transmembrane conductance regulator), the defective protein in cystic fibrosis (CF), not only is regulated by redox state but also directly modulates the epithelial redox environment through transepithelial flux of glutathione. The purpose of this review is to explore the potential therapeutic interest of antioxidant molecules in CF.Recent findings Several antioxidants have been shown to have mucolytic and anti-inflammatory properties. Some antioxiclants such as zinc and vitamin C may also help increase epithelial chloride secretion through CFTR-dependent and independent pathways. Other antioxidants are showing promise in helping CFTR mobilization to plasma membranes.Summary The many levels of potential application offered by antioxidants make this class of molecules one of the promising areas of therapeutic development for CF. Several redox-modulating agents have a high likelihood of providing useful approaches for the treatment of many aspects of CF airway disease.